Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc. 1997 May; 29(3):1905-6.